Hong Kong Stock Movement | GenFleet Therapeutics-B (02595.HK) rose over 8% in early trading; the company announced multiple clinical results for its KRAS G12D inhibitor.

Zhito Finance APP has learned that GenFleet Therapeutics-B (02595.HK) rose more than 8% in early trading. As of press time, it was up 4.42% at HK$28.38, with a turnover of HK$50.3292 million.